Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL
ISIN : THA520010002
Compare
Compare
Traded in other countries / regions
JSP.Thailand IPO Date
2021-11-02Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.44 | |||||
Debt-to-EBITDA | 2.26 | |||||
Interest Coverage | 7.31 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.96 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.7 | |||||
3-Year EBITDA Growth Rate | 75.3 | |||||
3-Year FCF Growth Rate | 19.5 | |||||
3-Year Book Growth Rate | -6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.44 | |||||
9-Day RSI | 54.14 | |||||
14-Day RSI | 51.93 | |||||
3-1 Month Momentum % | -13.2 | |||||
6-1 Month Momentum % | -12.31 | |||||
12-1 Month Momentum % | 4.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.33 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 76.18 | |||||
Days Sales Outstanding | 50.28 | |||||
Days Payable | 36.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.62 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 59.8 | |||||
Forward Dividend Yield % | 5.33 | |||||
5-Year Yield-on-Cost % | 5.62 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | 1.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.81 | |||||
Operating Margin % | 11.41 | |||||
Net Margin % | 6.18 | |||||
EBITDA Margin % | 18.07 | |||||
FCF Margin % | -19.31 | |||||
OCF Margin % | 9.06 | |||||
ROE % | 6.81 | |||||
ROA % | 4.36 | |||||
ROIC % | 4.02 | |||||
3-Year ROIIC % | 16.24 | |||||
ROC (Joel Greenblatt) % | 10.08 | |||||
ROCE % | 9.43 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.58 | |||||
PE Ratio without NRI | 13.8 | |||||
PEG Ratio | 1.42 | |||||
PS Ratio | 0.86 | |||||
PB Ratio | 0.93 | |||||
Price-to-Tangible-Book | 0.97 | |||||
Price-to-Operating-Cash-Flow | 9.53 | |||||
EV-to-EBIT | 11.19 | |||||
EV-to-EBITDA | 6.87 | |||||
EV-to-Revenue | 1.25 | |||||
EV-to-FCF | -6.41 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.36 | |||||
Price-to-Graham-Number | 0.77 | |||||
Earnings Yield (Greenblatt) % | 8.94 | |||||
FCF Yield % | -22.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JSP Pharmaceutical Manufacturing (Thailand) PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 983.793 | ||
| EPS (TTM) (฿) | 0.131 | ||
| Beta | 0.505 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.73 | ||
| Volatility % | 30.34 | ||
| 14-Day RSI | 51.93 | ||
| 14-Day ATR (฿) | 0.039581 | ||
| 20-Day SMA (฿) | 1.7585 | ||
| 12-1 Month Momentum % | 4.27 | ||
| 52-Week Range (฿) | 1.56 - 2.16 | ||
| Shares Outstanding (Mil) | 474.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JSP Pharmaceutical Manufacturing (Thailand) PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JSP Pharmaceutical Manufacturing (Thailand) PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.047400 Cash Dividend | 2026-04-28 | 1.92 (-2.04%) | ||
| THB 0.052600 Cash Dividend | 2025-08-26 | 1.93 (+3.76%) | ||
| THB 0.031600 Cash Dividend | 2024-08-28 | 2.14 (-0.93%) |
Show
Entries
JSP Pharmaceutical Manufacturing (Thailand) PCL Frequently Asked Questions
What is JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP)'s stock price today?
The current price of BKK:JSP is ฿1.78. The 52 week high of BKK:JSP is ฿2.16 and 52 week low is ฿1.56.
When is next earnings date of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP)?
The next earnings date of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is .
Does JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) pay dividends? If so, how much?
The Dividend Yield %  of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is 5.62% (As of Today), Highest Dividend Payout Ratio of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) was 0.41. The lowest was 0.12. And the median was 0.26. The  Forward Dividend Yield % of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is 5.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on JSP Pharmaceutical Manufacturing (Thailand) PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers